Cargando…
Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease lacking effective treatments. This is due, in part, to a complex and incompletely understood pathophysiology. To shed light, we conducted untargeted metabolomics on plasma from two independent cross-sectional ALS cohorts versus...
Autores principales: | Goutman, Stephen A, Guo, Kai, Savelieff, Masha G, Patterson, Adam, Sakowski, Stacey A, Habra, Hani, Karnovsky, Alla, Hur, Junguk, Feldman, Eva L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762943/ https://www.ncbi.nlm.nih.gov/pubmed/35088843 http://dx.doi.org/10.1093/brain/awac025 |
Ejemplares similares
-
Untargeted metabolomics yields insight into ALS disease mechanisms
por: Goutman, Stephen A, et al.
Publicado: (2020) -
Extracellular Vesicles in Serum and Central Nervous System Tissues Contain microRNA Signatures in Sporadic Amyotrophic Lateral Sclerosis
por: Lo, Ting-wen, et al.
Publicado: (2021) -
Intraspinal Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis: Phase 1 Trial Outcomes
por: Feldman, Eva L, et al.
Publicado: (2014) -
Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis
por: Paez-Colasante, Ximena, et al.
Publicado: (2020) -
Gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics
por: Guo, Kai, et al.
Publicado: (2023)